China unveiled its “No. 1 central document” for 2025, shedding light on the comprehensive health industry. The analysis of the document is essential for the industry to conduct policy learning and achieve industrial upgrading. Meanwhile, CFI is committed to improving the system for new products, with all-channel empowerment on new product marketing.

In order to help distributors follow the guiding principles of the document, have a better understanding of the document, and ensure new product marketing is under the guidance of the No. 1 central document. On March 10th, relevant departments gave an online lecture, to make sure that the profundity of this document is achieved with lightness, focusing on the new product features and its positioning.

To ensure the accuracy of the information mentioned in the lecture, CFI put great emphasis on market superiority and policy circumstances. Through the detailed analysis of the No. 1 central document, CFI underlines the importance of transforming the dividend policy into a sales drive. Group leader stated that, the new requirements put forward by the central policy in the field of comprehensive health. For CFI, This is a challenge also an opportunity. Therefore, the professional team should focus on its growth, grasp the industrial dynamics, to offer strong support to brick-and-mortar dealers.

In the next step, the Group will deploy a special team to meet the market demand, ensure that dealers can keep up with the Group's curriculum, face market changes, and steadily improve sales efficiency and sales capacity.